Search research articles
Contact Us
Filters
Showing results (31-40 of 189) with videos related to
Page
of 19
Sort By:
Statistics in Medicine
|
October 29, 2018
A Bayesian design for phase I cancer therapeutic vaccine trials
Chenguang Wang, Gary L Rosner, Richard B S Roden
Human Pathology
|
August 7, 2004
Vaccination to prevent and treat cervical cancer
Richard B S Roden, Morris Ling, T-C Wu
Plos Pathogens
|
May 20, 2016
Immunizing against Anogenital Cancer: HPV Vaccines
Cloe S Pogoda, Richard B S Roden, Robert L Garcea
Chest
|
July 14, 2000
An uncommon etiology of isolated pleural effusion. The ovarian hyperstimulation syndrome
S Roden, K Juvin, J P Homasson, et al.
Proteomics
|
November 25, 2011
Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics
Yuan Tian, Zhihao Yao, Richard B S Roden, et al.
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 15, 2005
Human papillomavirus vaccines for the prevention and treatment of cervical cancer
Todd T Tomson, Richard B S Roden, T-C Wu
British Journal of Clinical Pharmacology
|
November 1, 1982
Variations in responses to non-steroidal anti-inflammatory drugs
D L Scott, S Roden, T Marshall, et al.
Vaccine
|
May 4, 2010
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
Subhashini Jagu, Kihyuck Kwak, Robert L Garcea, et al.
Journal of Clinical Medicine
|
April 3, 2021
RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates
Bettina Huber, Joshua Weiyuan Wang, Richard B S Roden, et al.
Immunology and Cell Biology
|
May 8, 2009
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
Balasubramanyam Karanam, Subhashini Jagu, Warner K Huh, et al.
Page
of 19
Search research articles
Search
Showing results (31-40 of 189) with videos related to
Sort By:
Page
of 19
Statistics in Medicine
|
October 29, 2018
A Bayesian design for phase I cancer therapeutic vaccine trials
Chenguang Wang, Gary L Rosner, Richard B S Roden
Human Pathology
|
August 7, 2004
Vaccination to prevent and treat cervical cancer
Richard B S Roden, Morris Ling, T-C Wu
Plos Pathogens
|
May 20, 2016
Immunizing against Anogenital Cancer: HPV Vaccines
Cloe S Pogoda, Richard B S Roden, Robert L Garcea
Chest
|
July 14, 2000
An uncommon etiology of isolated pleural effusion. The ovarian hyperstimulation syndrome
S Roden, K Juvin, J P Homasson, et al.
Proteomics
|
November 25, 2011
Identification of glycoproteins associated with different histological subtypes of ovarian tumors using quantitative glycoproteomics
Yuan Tian, Zhihao Yao, Richard B S Roden, et al.
Current Opinion in Investigational Drugs (London, England : 2000)
|
January 15, 2005
Human papillomavirus vaccines for the prevention and treatment of cervical cancer
Todd T Tomson, Richard B S Roden, T-C Wu
British Journal of Clinical Pharmacology
|
November 1, 1982
Variations in responses to non-steroidal anti-inflammatory drugs
D L Scott, S Roden, T Marshall, et al.
Vaccine
|
May 4, 2010
Vaccination with multimeric L2 fusion protein and L1 VLP or capsomeres to broaden protection against HPV infection
Subhashini Jagu, Kihyuck Kwak, Robert L Garcea, et al.
Journal of Clinical Medicine
|
April 3, 2021
RG1-VLP and Other L2-Based, Broad-Spectrum HPV Vaccine Candidates
Bettina Huber, Joshua Weiyuan Wang, Richard B S Roden, et al.
Immunology and Cell Biology
|
May 8, 2009
Developing vaccines against minor capsid antigen L2 to prevent papillomavirus infection
Balasubramanyam Karanam, Subhashini Jagu, Warner K Huh, et al.
Page
of 19